<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-3-6.anc" start="15814" end="15818" sStart="15762" offset="52" sid="r7.1.use.v.0410" wn="1" wnkey="use%2:34:01::" text="Only 7% of patients managed without drugs used any test strips during the year." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-3-6.anc" start="20014" end="20019" sStart="null" offset="21" sid="r7.1.use.v.0310" wn="2" wnkey="use%2:34:02::" text="For patients using oral medications, older age and lower neighborhood SES were also associated with lower odds of initiating SMBG." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6963-3-6.anc" start="25340" end="25344" sStart="null" offset="0" sid="null" wn="3" wnkey="time%1:28:00::" text="Furthermore, the structure of the pharmacy benefit at the &lt;b&gt;time&lt;/b&gt; of our study makes it very likely that all test strip dispensings would occur in health plan pharmacies." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-3-6.anc" start="19497" end="19504" sStart="null" offset="13" sid="r8.suggest.v.0204" wn="3" wnkey="suggest%2:32:02::" text="Our findings suggest that managed care patients who may benefit the most from intensive diabetes management may be least likely to self-monitor blood glucose." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-3-6.anc" start="3200" end="3207" sStart="null" offset="89" sid="r7.serve.v.0104" wn="4" wnkey="serve%2:41:00::" text="Harvard Vanguard Medical Associates (HVMA) is a multi-specialty group practice serving nearly 300,000 people in diverse ethnic and socioeconomic communities in and around Boston, Massachusetts." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-3-6.anc" start="6378" end="6390" sStart="null" offset="103" sid="r11.recommend.v.0502" wn="1" wnkey="recommend%2:32:01::" text="Cut points for regular use were based on dispensing patterns and recent guidelines recommending testing three to four times per day for insulin users and less frequent testing for non-insulin users." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-3-6.anc" start="15361" end="15372" sStart="null" offset="30" sid="r11.recommend.v.0503" wn="2147483645" wnkey="null" text="SMBG frequency was well below recommended guidelines for both insulin and sulfonylurea patients (Table 2)." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-3-6.anc" start="526" end="537" sStart="null" offset="137" sid="r11.recommend.v.0501" wn="1" wnkey="recommend%2:32:01::" text="While the efficacy of self-monitoring independent of other self-management practices is still uncertain, the practice is recommended for patients using either insulin or oral drug therapy." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-3-6.anc" start="27196" end="27200" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="All authors &lt;b&gt;read&lt;/b&gt; and approved of the final manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-3-6.anc" start="9701" end="9705" sStart="null" offset="0" sid="null" wn="4" wnkey="poor%3:00:02::" text="We categorized the last recorded HbA1c test value for each individual into two dichotomous measures representing &lt;b&gt;poor&lt;/b&gt; and very &lt;b&gt;poor&lt;/b&gt; glycemic control (i.e." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-3-6.anc" start="9715" end="9719" sStart="null" offset="147" sid="r7.poor.j.0601" wn="4" wnkey="poor%3:00:02::" text="We categorized the last recorded HbA1c test value for each individual into two dichotomous measures representing poor and very poor glycemic control (i.e." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-3-6.anc" start="8839" end="8843" sStart="null" offset="109" sid="r7.poor.j.0281" wn="4" wnkey="poor%3:00:02::" text="Clinical assessments of health status as measures of susceptibility or potential for the threat of poor health outcomes included two dichotomous measures of body mass index [ 14 ] (i.e." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-3-6.anc" start="9701" end="9705" sStart="null" offset="0" sid="null" wn="5" wnkey="poor%5:00:00:insufficient:00" text="We categorized the last recorded HbA1c test value for each individual into two dichotomous measures representing &lt;b&gt;poor&lt;/b&gt; and very &lt;b&gt;poor&lt;/b&gt; glycemic control (i.e." />
  </sentences>
</list>